• PHONE: 617-353-3775
  • EMAIL:  cockburn@bu.edu
  • WEBSITE: http://people.bu.edu/cockburn/
  • OFFICE: 645A
  • OFFICE HOURS: By Appointment
    Questrom School of Business
    Rafik B. Hariri Building
    595 Commonwealth Avenue
    Boston, MA 02215
  • EDUCATION Open or Close

    PH D, Harvard University, Economics, 1990.

    MA, Harvard University, Economics, 1987.

    BSC, Queen Mary College University of London, Economics and Political Science, 1984.

  • CURRENT COURSESOpen or Close

    GSM EM715 A1 Value Creation and Performance Management

    GSM SI814 P1 Intellectual Property Strategies

  • PUBLICATIONSOpen or Close


      Cockburn, I. M., Lanjouw, J., & Schankerman, M. (2016). Patents and the Global Diffusion of New Drugs. American Economic Review, 106(1), 136-164.
      See Publication Online

      Agrawal, A., Cockburn, I. M., & Zhang, L. (2015). Deals Not Done: Sources of Failure in the Market for Ideas. Strategic Management Journal, 36(7), 976-986.
      See Publication Online

      Freedman, L., Cockburn, I. M., & Simcoe, T. (2015). The Economics of Reproducibility in Preclinical Research. PLOS Biology, 13(6), e1002165.
      See Publication Online

      Berndt, E., & Cockburn, I. M. (2014). The Cost of Low Prices: Access to New Drugs in India. Health Affairs, 33(9), 1567-1575.

      Berndt, E., & Cockburn, I. M. (2014). Price Indexes for Clinical Trial Research. Monthly Labor Review, (June 17), US Dept. Labor, Washington, DC.

      Agrawal, A., Cockburn, I. M., Galasso, A., & Oettl, A. (2014). Why are some regions more innovative than others? The role of small firms in the presence of large labs. Journal of Urban Economics, 81(1), 149-165.

      Mueller, E., Cockburn, I. M., & MacGarvie, M. (2013). Access to Intellectual Property for Innovation: Evidence on Problems and Coping Strategies from German Firms. Research Policy, 42(2), 529-541.

      Klies, L., Chwelos, P., Ramirez, R., & Cockburn, I. M. (2012). Information Technology and Intangible Output: The Impact of IT Investment on Innovation Productivity. Information Systems Research, 23(1), 42-59.

      Berndt, E., Blalock, N., & Cockburn, I. M. (2011). Diffusion of New Drugs in the Post-TRIPs Era. International Journal of the Economics of Business, 18(2), 203-224.

      Cockburn, I. M., & MacGarvie, M. (2011). Entry and Patenting in the Software Industry. Management Science, 57(5), 915-933.

      Cockburn, I. M., Bollyky, T., & Berndt, E. (2010). Bridging the gap: improving clinical development and the regulatory pathways for health products for neglected diseases. Clinical Trials, 7(6), 719-734.

      Cockburn, I. M., MacGarvie, M., & Müller, E. (2010). Patent Thickets, Licensing and Innovative Performance. Industrial and Corporate Change, 19(3), 899-925.

      Cockburn, I. M., & Slaughter, M. (2010). The Global Location of Biopharmaceutical Knowledge Activity: New Findings, New Questions. Innovation Policy and the Economy, 10(1), 129-157. Chicago, IL.

      Cockburn, I. M., Stern, S., & Stern, S. (2010). Finding the Endless Frontier: Lessons from the Life Sciences Innovation System for Technology Policy. Capitalism and Society, 5(1), 1-48.

      Agrawal, A., Cockburn, I., & Rosell, C. (2010). Not Invented Here? Innovation in Company Towns. Journal of Urban Economics, 67(1), 78-89.

      Wagner, S., & Cockburn, I. M. (2010). Patents and the Survival of Internet-related IPOs. Research Policy, 39(2), 214-228.

      Cockburn, I., & MacGarvie, M. (2009). Patents, Thickets and the Financing of Early-Stage Firms: Evidence from the Software Industry. Journal of Economics and Management Strategy, 18(3), 729-733.

      Cockburn, I. M., Berneman, L., Agrawal, A., & Iyer, S. (2009). US/Canadian Licensing in 2007/2008: Survey Results. les Nouvelles: Journal of the Licensing Executives Society, XLIV(1), 1-8.

      Chwelos, P., Berndt, E., & Cockburn, I. (2008). Faster, Smaller, Cheaper: An Hedonic Price Analysis of PDAs. Applied Economics, 40(20), 2839-2856.

      Cockburn, I. (2007). Is the Pharmaceutical Industry in a Productivity Crisis?. Innovation Policy and the Economy, 7, 1-32.

      Agrawal, A., Cockburn, I., & McHale, J. (2006). Gone But Not Forgotten: Labor Flows, Knowledge Spillovers, and Enduring Social Capital. Journal of Economic Geography, 6(5), 571-591.

      Grabowski, H., Cockburn, I., & Long, G. (2006). The Market for Follow-on Biologics: How Will it Evolve?. Health Affairs, 25(5), 1291-1301.

      Cockburn, I., Henderson, R., & Stern, S. (2000). Untangling the Origins of Competitive Advantage. Strategic Management Journal, 21(10-11), 1123-1145.

      Henderson, R., & Cockburn, I. (1996). Scale, Scope, and Spillovers: Determinants of Research Productivity in the Pharmaceutical Industry. RAND Journal of Economics, 27(1), 32-59.

      Henderson, R., & Cockburn, I. (1994). Measuring Competence: Exploring Firm Effects in Pharmaceutical Research. Strategic Management Journal, 15, 63-84.


      Cockburn, I. (2006). in Blurred Boundaries: Tensions Between Open Scientific Resources and Commercial Exploitation of Knowledge in Biomedical Research, Chapter in B. Kahin and D. Foray (eds.) "Advancing Knowledge and the Knowledge Economy" Cambridge, MA: MIT Press, pp 351-369.

      Cockburn, I. (2005). in State Street Meets the Human Genome Project: Intellectual Property and Bioinformatics. Chapter in R. Hahn (ed.) Intellectual Property Rights in Frontier Industries: Biotechnology and Software Washington, DC: AEI-Brookings Press.

      Cockburn, I., Kortum, S., & Stern, S. (2003). in Are All Patent Examiners Equal? Examiners, Patent Characteristics and Litigation Outcomes. Chapter in W. Cohen and S. Merrill (eds.) Patents in the Knowledge-based Economy Washington, DC: National Academies Press.


      Berndt, E., & Cockburn, I. M. (2013). Price Indexes for Clinical Trial Research: A Feasibility Study. Cambridge: National Bureau of Economic Research.
      See Publication Online



      Cockburn, I. M. (Presenter & Author), & Schankerman, M. (Author Only). OHE Seminar, Patents, Price Controls and Access to New Drugs, Office of Health Economics, London, UK. (June 6, 2016).

      Cockburn, I. M. (Presenter & Author). NBER Summer Institute, Discussant Remarks: K. Bryan "R&D Policy and the Direction of Innovation", NBER, Cambridge MA. (July 15, 2014).

      Cockburn, I. M. (Author Only), Lanjouw, J. (Author Only), & Schankerman, M. (Presenter & Author). TIGER Forum Economics and Health Care and Pharmaceuticals, Patent Rights and Global Diffusion of New Drugs, Toulouse School of Economics, Toulouse, France. (June 30, 2014).

      Cockburn, I. M. (Presenter & Author), & Berndt, E. (Presenter & Author). BRDPI Workshop, An Experimental Price Index for Clinical Trials Research, National Institutes of Health, Office of the Director, Washington, DC. (June 11, 2014).

      Cockburn, I. M. (Presenter & Author). Conference on Patents and the Innovation Economy, Patents and the Global Diffusion of New Drugs, Hoover Institution, Stanford. CA. (January 31, 2014).

      Cockburn, I. M. (Presenter & Author), Lanjouw, J. (Author Only), & Schankerman, M. (Author Only). TIES Seminar, Global Diffusion of New Drugs, MIT Sloan School, Cambridge MA. (October 28, 2013).

      Agrawal, A. (Author Only), Cockburn, I. M. (Presenter & Author), & Zhang, L. (Author Only). Conference on Patent Use, Deals not done: Sources of failure in the market for ideas, UK Intellectual Property Office, London. (September 9, 2013).

      Berndt, E. (Author Only), & Cockburn, I. M. (Presenter & Author). Price Indexes for Clinical Trial Research, Bureau of Economic Analysis, US Dept. of Commerce, Washington, DC. (May 9, 2013).

      Cockburn, I. (Presenter and Author). FTC/DOJ Patent Assertion Entity Activities Workshop, Costs of Patent Assertion Entities, Federal Trade Commision/Department of Justice, Washington, DC. (December 10, 2012).

      Cockburn, I. (Panelist). USPTO Roundtable, Director's Working Meeting on Patent Fees, US Patent and Trademark Office, Alexandria, VA. (August 16, 2011).


      Ali, A. (Presenter & Author), & Cockburn, I. M. (Author Only). IP Statistics for Decision Makers 2015, Timing of LIcensing, European Patent Office, Vienna. (November 3, 2015).

  • GENERAL SERVICEOpen or Close


      QST, Strategy & Innovation Department, Department Chair. (July 1, 2016 - Present).

      QST, Other Questrom Service Area, APT Chair. (July 1, 2015 - July 1, 2016).


    Member, Conference on Research in Income and Wealth. (July 1, 2011 - Present).

    Richard C. Shipley Professor in Management, Boston University School of Management. (July 2011 - Present).

    Professor of Strategy and Innovation, Boston University School of Management. (July 1, 2010 - Present).

    Research Associate, National Bureau of Economic Research. (July 26, 1997 - Present).

    Visiting Scholar, MIT Sloan School of Management. (September 1, 2013 - June 30, 2014).

    Professor of Finance and Economics, Boston University School of Management. (September 1999 - September 2010).

    VanDusen Professor of Business Administration, Faculty of Commerce, University of British Columbia. (July 1998 - July 2000).

    Visiting Scholar, Harvard University, Department of Economics. (July 1996 - June 1997).

  • AWARDS AND HONORSOpen or Close

    IDEAS Top 5% of Economists Worldwide, IDEAS, Research. (December 30, 2016).

    Ranked in the top 5% of 48,918 of registered authors based on 24 different citation-based bibliometric measures constructed from 2,200,000 publications.

    Molly McCombe and T.J. Callahan Faculty Research Award, Questrom School of Business, Research. (September 23, 2016).
    The McCombe award provides research support to faculty conducting and disseminating cutting-edge, hihg-impact, high-potential research of strategic importance to the School

    Richard C. Shipley Professor of Management, Teaching. (July 1, 2011).

    Dan & Mary Lou Schendel Best Paper Prize 2010, Strategic Management Journal, Research. (September 1, 2010).